Research
Metabolic adaptation
Heterogeneous results were observed regarding the degree of glycemic control associated with optimal macrovascular disease risk reduction.
Clinicians should be aware of the variability in glycemic control outcomes when treating T2DM.
StrongQualifiesmedium confidence
Heterogeneous results pertaining to the degree of glycemic control associated with optimal macrovascular disease risk reduction, as well as the safest pharmacologic means to do so, were observed.
Why this rating
The review of multiple trials provides a strong basis for this claim.
Source
Cardiovascular Outcomes Trials in Type 2 Diabetes Mellitus
Karan Kapoor et al. · Cardiology · 2016
reviewCited 5×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →